TerrAscend Corp. ( TSNDF) - Stock Earnings
TSNDF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
TSNDF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -9.8 million USD | 65.1 million USD |
| 2025Q4 | 12.6 million USD | 65.7 million USD |
| 2026Q1 | -8.7 million USD | 65.5 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TSNDF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.1 million USD | 317.3 million USD |
| 2024 | -32.5 million USD | 306.7 million USD |
| 2025 | -70.4 million USD | 260.1 million USD |
| 2026 Est. | — | — |
TSNDF
Price: $0.55
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.04 USD
P/E Ratio: 15.88
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 235.0 million